Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
RATTUS NORVEGICUS (EDG3)
Document Type and Number:
WIPO Patent Application WO/2001/027137
Kind Code:
A2
Abstract:
Rattus norvegicus EDG3 polypeptides and polynucleotides and method for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for screening for compounds which either agonize or antagonize Rattus norvegicus EDG3. Such compounds are expected to be useful in treatment of human diseases, including, but not limited to: infections such as bacterial, fungal, protozoan and viral infections, particularly infections caused by HIV-1 or HIV-2; pain; cancers; diabetes, obesity; anorexia; bulimia; asthma; Parkinson's disease; acute heart failure; hypotension; hypertension; urinary retention; osteoporosis; angina pectoris; myocardial infarction; stroke; ulcers, asthma; allergies; benign prostatic hypertrophy; migraine; vomiting; psychotic and neurological disorders, including anxiety, schizophrenia, manic depression, depression, dementia, and severe mental retardation; and dyskinesias, such as Huntington's disease or Gilles de la Tourett's syndrome.

Inventors:
LANE PAMELA
TSUI PING
ELSHOURBAGY NABIL
Application Number:
PCT/US2000/028231
Publication Date:
April 19, 2001
Filing Date:
October 12, 2000
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SMITHKLINE BEECHAM CORP (US)
SMITHKLINE BEECHAM PLC (GB)
International Classes:
C07K14/705; (IPC1-7): C07K/
Foreign References:
US5912144A1999-06-15
US6130067A2000-10-10
Other References:
ZHANG G. ET AL.: 'Comparative analysis of three murine G-protein coupled receptors activated by sphingosine-1- phosphate' GENE vol. 227, February 1999, pages 89 - 99
DATABASE GENBANK [Online] 26 September 1999 NAKAJIMA N. ET AL. Database accession no. AF184914
DATABASE GENBANK [Online] 27 November 1997 MARRIA M. ET AL. Database accession no. AA672296
DATABASE GENBANK [Online] 08 September 1998 MARRA M. ET AL. Database accession no. AI115954
Attorney, Agent or Firm:
Andersen, Robert L. (301 One Westlakes P.O. Box 98, Valley Forge PA, US)
Prestia, Paul F. (301 One Westlakes Berwyn, P.O. Box 98, Valley Forge PA, US)
Download PDF:
Claims:
What is claimed is: (US PTO)
1. An isolated polynucleotide selected from the group consisting of : (i) an isolated polynucleotide comprising a nucleotide sequence encoding a polypeptide having at least a 95% identity to the amino acid sequence of SEQ IID NO : 2, over the entire length of SEQ ID NO : 2; (ii) an isolated polynucleotide comprising a nucleotide sequence having at least a 95% identity over its entire length to a nucleotide sequence encoding the polypeptide of SEQ ID NO : 2; (iii) an isolated polynucleotide comprising a nucleotide sequence having at least a 95% identity to that of SEQ ID NO: 1 over the entire length of SEQ ID NO: 1; (iv) an isolated polynucleotide comprising a nucleotide sequence encoding the polypeptide of SEQ ID N0 : 2; (v) an isolated polynucleotide that is the polynucleotide of SEQ ID NO : 1 ; or (vi) an isolated polynucleotide with a nucleotide sequence of at least 100 nucleotides in length obtained by screening an appropriate library under stringent hybridization conditions with a labeled probe having the sequence of SEQ ID NO: 1 or a fragment thereof of at least 15 nucleotides; or a nucleotide sequence complementary to said isolated polynucleotide.
2. An isolated polypeptide selected from the group consisting of : (i) an isolated polypeptide having at least a 95% identity to the amino acid sequence of SEQ ID NO: 2 over the entire length of SEQ ID N0 : 2; (ii) an isolated polypeptide comprising the amino acid sequence of SEQ ID N0 : 2; or (iii) an isolated polypeptide that is the amino acid sequence of SEQ ID N0 : 2.
3. A method for screening to identify compounds that stimulate or that inhibit a function or level of the polypeptide of Claim 2, comprising a method selected from the group consisting of : (a) measuring or, quantitatively or qualitatively, detecting the binding of a candidate compound to the polypeptide (or to the cells or membranes bearing the polypeptide) or a fusion protein thereof by means of a label directly or indirectly associated with the candidate compound; (b) measuring the competition of the binding of a candidate compound to the polypeptide (or to the cells or membranes bearing the polypeptide) or a fusion protein thereof in the presence of a labeled competitor; (c) testing whether the candidate compound results in a signal generated by activation or inhibition of the polypeptide, using detection systems appropriate to the cells or cell membranes bearing the polypeptide; (d) mixing a candidate compound with a solution comprising a polypeptide of Claim 2, to form a mixture, measuring activity of the polypeptide in the mixture, and comparing the activity of the mixture to a to a control mixture which contains no candidate compound; or (e) detecting the effect of a candidate compound on the production of mRNA encoding said polypeptide and said polypeptide in cells.
4. An agonist or an antagonist of the polypeptide of Claim 2.
5. An agonist or an antagonist of the Rattus norvegicus EDG3 polypeptide identified by the method of Claim 3.
6. An expression system comprising a polynucleotide capable of producing a polypeptide of Claim 2 when said expression system is present in a compatible host cell.
7. A process for producing a recombinant host cell comprising the step of introducing the expression vector of Claim 6 into a cell, such that the host cell, under appropriate culture conditions, produces said polypeptide.
8. A recombinant host cell produced by the process of Claim 7.
9. A membrane of a recombinant host cell of Claim 8 expressing said polypeptide.
10. A process for producing a polypeptide comprising culturing a host cell of Claim 9 under conditions sufficient for the production of said polypeptide and recovering said polypeptide from the culture.
Description:
INTERNATIONAL SEARCH REPORT International application No. PCTsIJS00/2823 1 C (Continuation). DOCUMENTS CONSIDERED TO BE RELEVANT Category* Citation of document. with indication, where appropriate, of the relevant passages Relevant to claim No. P, A US 6,130,067 A (TSUI, P.) 10 October 2000, col. 6-7.6-10 INTERNATIONAL SEARCH REPORT Intemational application No. PCT/US00/28231 zox I Observations where certain claims were found unsearchable (Continuation of item 1 of first sheet) This international report has not been established in respect of certain claims under Article 17 (2Xa) for the following reasons: 1. n Claims Nos. : I because thev relate to subject matter not required to be searched by this Authority. namely : 2. ! Claims Nos.: because they relate to parts of the international application that do not comply with the prescribed requirements to such an extent that no meaningful intemational search can be carried out, specifically : 3. f Claims Nos.: because they are dependent claims and are not drafted in accordance with the second and third sentences of Rule 6.4 (a). Box 11 Observations where unity of invention is lacking (Continuation of item 2 of first sheet) This International Searching Authority found muitiple inventions in this international application, as follows : Please See Extra Sheet. ) ! ! As all required additional search fees . vere timely paid by the applicant, this intemational search report covers all searchable claims. 2. g As all searchable claims could be searched without effort justifying an additional tee. this Authority did not invite payment of anv additional tee 3. As on) y some ot the required additional search fees were timelv paid by the applicant, this international search report covers only those claims for which tees xnere paid. specifically claims Nos.: 4. n No required additional search tees were timely paid bs the applicant. Consequently. this intemational search report is restricted to the invention first mentioned in the claims : it is covered by claims Nos.: 1-2 and 6-10 Remark on Protest The additional search tees were accompanied bv the applicant's protest. No protest accompanied the paument ot additional search tees INTERNATIONAL SEARCH REPORT International application No. PCT,'LJSOO/28231 BOX 11. OBSERVATIONS WHERE UNITY OF INVENTION WAS LACKING This ISA found multiple inventions as follosrs : This application contains the following inventions or groups of inventions which are not so linked as to form a single inventive concept under PCT Rule 13. 1. In order for all inventions to be searched, the appropriate additional search fees must be paid. Group 1. claim (s) 1-2 and 6-10. drawn to polypeptides. polynucleotides encoding such, vectors thereof, host cells, and recombinant expression and purification of such. Group II. claim (s) 3, drawn to a method for screening to identify compounds. Group III, claim (s) 4-5. drawn to an agonist or an antagonist of the polypeptide. The inventions listed as Groups I-III do not relate to a single inventive concept under PCT Rule 13.1 because, under PCT Rule 13. 2, they lack the same or corresponding special technical features for the following reasons: This authority considers that the main invention in the instant application comprises the first-recited product, polvnucleotide encoding Rattus Norvegicus EDG3. and the first-recited method of using that product, namely in the process of producing the encoded pohpeptide Note that there is no method of making the polynucleotide. Also included in this group is the product made. namely the encoded polypeptide, the vector and host cell comprising the polynucleotide. The materially and functionallv dissimilar products of group III and the additional method of group II do not share a special technical feature within the meaning of PCT Rule 13. 2 and thus do not relate to a single invention concept within the meaning of PCT Rule 13. 1